Literature DB >> 1310238

The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin.

M Lortie1, D Regoli, N E Rhaleb, G E Plante.   

Abstract

Bradykinin (BK) is known to induce diuresis (UV), natriuresis (UNaV), and increased renal blood flow (RPF) with little or no change in glomerular filtration rate (GFR). In this study, BK is infused alone and concurrently with B1- or B2-kinin receptor antagonists into the left kidney of pentobarbital-anesthetized dogs. The intrarenal infusion of BK (bolus: 0.5 microgram/kg, followed by a sustaining dose: 0.05 micrograms.kg-1.min-1) affected left kidney function only. In the left kidney, UV increased from 0.42 +/- 0.21 to a maximum of 1.88 +/- 0.55 ml/min (P less than 0.01) and UNaV rose from 55 +/- 13 to 160 +/- 17 mueq/min (P less than 0.01), while RPF was enhanced from 86 +/- 11 to 125 +/- 24 ml/min (P less than 0.05), and GFR remained unchanged. When a B1-receptor antagonist ([Leu8]-des-Arg9-BK; 2.0 micrograms.kg-1.min-1) was infused concurrently with BK, the increase in urine flow was not different from BK alone. UNaV was transiently attenuated by 50% in this group (P less than 0.05). A B2-receptor antagonist (D-Arg0,[Hyp3,D-Phe7]-BK; 2.0 micrograms.kg-1.min-1) infused with BK significantly (P less than 0.05) and selectively inhibited by 50% the maximal diuresis provoked by BK alone. UNaV in this group was not different from that induced by BK alone. Finally, the concurrent infusion of either B1- or B2-antagonist completely inhibited the rise in RPF observed when BK was infused alone. We conclude that BK infused into the renal artery of dogs in vivo can alter UV and UNaV independently of global renal hemodynamic (RPF and GFR) changes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310238     DOI: 10.1152/ajpregu.1992.262.1.R72

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.

Authors:  Erika Kajdácsi; Péter K Jani; Dorottya Csuka; Lilian Varga; Zoltán Prohászka; Henriette Farkas; László Cervenak
Journal:  J Clin Immunol       Date:  2016-02-12       Impact factor: 8.317

2.  In vitro and in vivo effects of kinin B(1) and B(2) receptor agonists and antagonists in inbred control and cardiomyopathic hamsters.

Authors:  S Hallé; F Gobeil; J Ouellette; C Lambert; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Renal permeability alteration precedes hypertension and involves bradykinin in the spontaneously hypertensive rat.

Authors:  G E Plante; M Bissonnette; M G Sirois; D Regoli; P Sirois
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

4.  RMP-7 : Potential as an Adjuvant to the Drug Treatment of Brain Tumours.

Authors:  A V Boddy; H D Thomas
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

5.  Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.

Authors:  L Levesque; G Drapeau; J H Grose; F Rioux; F Marceau
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

6.  Detecting low-abundance vasoactive peptides in plasma: progress toward absolute quantitation using nano liquid chromatography-mass spectrometry.

Authors:  Mark Lortie; Steven Bark; Roland Blantz; Vivian Hook
Journal:  Anal Biochem       Date:  2009-07-16       Impact factor: 3.365

7.  Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs.

Authors:  N Nakhostine; C Ribuot; D Lamontagne; R Nadeau; R Couture
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  Vascular Kinin B1 and B2 Receptors Determine Endothelial Dysfunction through Neuronal Nitric Oxide Synthase.

Authors:  Thássio R R Mesquita; Gianne P Campos-Mota; Virgínia S Lemos; Jader S Cruz; Itamar C G de Jesus; Enilton A Camargo; Jorge L Pesquero; João B Pesquero; Luciano Dos Santos A Capettini; Sandra Lauton-Santos
Journal:  Front Physiol       Date:  2017-04-28       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.